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Abstract
Background: Nephrotic syndrome is a relatively rare but serious condition in children. Infantile nephrotic syndrome
often has a genetic origin; the treatment is then symptomatic, with a poor prognosis, and a rapid evolution to chronic
kidney disease. However, non-genetic infantile nephrotic syndrome has been identified. Here we report for the first
time in a child a nephrotic syndrome as the sole clinical expression of a cytomegalovirus infection.
Case presentation: The patient was 5 months old when he presented with a nephrotic syndrome. An exhaustive
genetic testing was conducted and came back negative. A viral work-up only showed a positive cytomegalovirus PCR.
Antiviral treatment lead to a complete remission of the nephrotic syndrome, with no requirement for steroid therapy.
Renal function remained normal throughout follow-up.
Conclusion: Nephrotic syndrome should always be carefully investigated in children. This observation reinforces the
connection between viral infections and pediatric nephrotic syndrome, sparking more controversy about an infectious
origin to childhood nephrotic disease.
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Background
In the first year of life, 66 % of the patients suffering from
hypoalbuminemia and severe proteinuria are diagnosed
with genetic nephrotic syndrome (GNS) [1]. Many muta-
tions can be responsible for GNS. NPHS1, encoding
nephrin, is involved in the Finnish type of GNS [2]; 2 main
variants are characterized, Fin-major (p.L41fsX91) which
represents 78 % of the described NPHS1 mutations in
Finland, and Fin-minor (p.R1109X) [3]. Podocin, a protein
which is encoded by the NPHS2 gene, has also been re-
ported in GNS cases. Noteworthy, immunosuppressive
treatments are often inefficient; the prognosis of the dis-
ease is poor, and renal transplantation is often necessary,
usually with no relapse.
However, non-genetic congenital or infantile neph-
rotic syndromes have been identified. They have to be
diagnosed early, since some of them can be treated in a
specific manner, and cured [4].
Case presentation
The patient was 5 months old when he presented with
acute gastroenteritis; he had no previous medical history,
except for 3 episodes of bronchiolitis. He had a twin
brother, from a dichorial diamniotic pregnancy; the twin
brother was in good health. The parents were Caucasian,
and not consanguineous. There was no significant family
medical history. Clinically, mild edema was noted on the
face and lower limbs. Serum creatinine was normal
(35 μmol/l, normal range 25–45 μmol/l), serum urea was
also normal (5.4 mmol/l, normal range 4–7 mmol/l). Total
serum protein came back low, measured at 35 g/l (normal
range 60–75 g/l), and albuminemia was also low, at 10.3 g/
l (normal values 35–45 g/l) as shown in Table 1. Protein-
uria was elevated, at 5.1 g/l, leading to a proteinuria/creati-
nuria ratio of 7.83 g/mmol. A renal ultrasound showed a
right kidney measured at 65 × 33 × 30 mm, and a left kid-
ney measured at 71 × 35 × 28 mm; the Doppler analysis
was normal. Kidney size remained stable throughout
follow-up, above average. There was no sign of blockage,
no stone, no tumor. A renal biopsy was performed, analyz-
ing 13 glomeruli; it showed a slight mesangial cell hyper-
trophy with no diffuse mesangial sclerosis; non-specific
tubular lesions were present, along with interstitial edema.
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No viral cytopathic inclusions could be seen. Electron mi-
croscopy was not performed. A viral work-up came back
negative for hepatitis A, B and C; syphilis and HIV serol-
ogies were also negative. A genetic testing showed no mu-
tation in NPHS1, NPHS2 nor WT1 genes. Hip and knee
radiographs were normal, eliminating a nail patella syn-
drome. At this stage, angiotensin converting enzyme in-
hibitor therapy was initiated; captopril was used, started at
3 mg/d, and increased to 6 mg/d after 15 days. Albumin
perfusions were performed initially, at a dose of 1 g/kg/d,
each day, for 16 days.
Epstein-Barr virus PCR test was negative; cytomegalo-
virus PCR test was positive, showing more than 123,000
copies/ml. Cerebral imaging showed no significant brain le-
sion; An EEG was performed and came back normal. Oph-
thalmoscopy was also normal. Ganciclovir was immediately
started and administered for 15 days; it was then switched
to valganciclovir for another 15-day period. By the end of
the antiviral therapy, proteinuria had decreased to 0.15 g/l;
albuminemia and total serum protein levels were back to
normal values. Captopril therapy could successfully be dis-
continued. No relapse had occurred in 30 months.
Discussion–Conclusion
Here we describe an infantile nephrotic syndrome, in rela-
tion with a CMV infection. Interestingly, the nephrotic
syndrome resolved when proper antiviral therapy was initi-
ated, supporting a causal relationship between infantile
nephrotic syndrome and cytomegalovirus infection. Note-
worthy, another case of cytomegalovirus related nephrotic
syndrome has been described [5]; but, as opposed to this
report, extra-renal symptoms were predominant over the
renal presentation. On the contrary, the clinical presenta-
tion reported here was misleading, since only a slight di-
gestive symptomatology was in favor of a systemic etiology.
This observation reinforces the connection between viral
infections and nephrotic syndrome in children [6], spark-
ing more controversy about an infectious origin to child-
hood nephrotic disease.
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Table 1 Evolution of albuminemia, total serum protein and proteinuria in a patient with cytomegalovirus-induced nephrotic syndrome
Time (d) Event Albuminemia (g/l) Total serum protein (g/l) Proteinuria (g/l) CMV viraemia (copies/ml)
0 10.3 35 5.1 123000
7 Albumin perfusions 24 52 4.8
15 ACE therapy 25 54 4.1
30 Ganciclovir perfusions 30.2 60.2 0.15 12000
45 Valganciclovir therapy 34 62 0.16
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